Replimune Group, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:REPL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 551.33 M469.51 M389.45 M333.59 M 총 부채 135.49 M132.79 M126.11 M123.05 M 자본금 총액 415.84 M336.71 M263.34 M210.54 M 총 부채 및 주주자본 551.33 M469.51 M389.45 M333.59 M 총부채 49.18 M49.61 M50.05 M50.49 M 순부채 -434.63 M-353.73 M-273.6 M-218.65 M

뉴스

Biotech Investors Are Tuning Out the MAHA Chaos

What's Going On With Replimune Stock On Tuesday? - Replimune Group (NASDAQ:REPL)

Replimune stock collapses 64% following FDA rejection

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

FDA Rejection Sparks Questions On Replimune Drug Approval Path - Replimune Group (NASDAQ:REPL)

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Replimune: Second CRL May Have Sealed RP1's Fate - It's Hard To See Positives (REPL)

FDA Review Looms As Replimune Faces Weak Technical Setup - Replimune Group (NASDAQ:REPL)

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer